Evolent Health (EVH) to Acquire Valence Health in $145M Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Leerink Partners Remains Bullish on Evolent Health (EVH) Following Investor Call
July 13, 2016 1:31 PM EDTLeerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with investors. On the call management highlighted that they would expect Valence to continue to grow in the ~30% range in 2017. Management also believes that their... More
FBR Capital Raises Price Target on Evolent Health (EVH) to $24 Following Valence Health Acquisitions
July 13, 2016 11:16 AM EDTFBR Capital reiterated an Outperform rating on Evolent Health (NYSE: EVH), and raised the price target to $24.00 (from $16.00), following the company's announced acquisition of most of the assets of Valence Health. In addition to bringing new expertise, EVH will benefit from using Valent for... More
